[HTML][HTML] Necroptosis in the pathophysiology of disease
Over the past 15 years, elegant studies have demonstrated that in certain conditions,
programed cell death resembles necrosis and depends on a unique molecular pathway with …
programed cell death resembles necrosis and depends on a unique molecular pathway with …
[HTML][HTML] Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease
WY Wang, MS Tan, JT Yu, L Tan - Annals of translational medicine, 2015 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain, which is
characterized by the formation of extracellular amyloid plaques (or senile plaques) and …
characterized by the formation of extracellular amyloid plaques (or senile plaques) and …
Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions
A Abeysinghe, R Deshapriya, C Udawatte - Life sciences, 2020 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder and is identified as the most
common cause for dementia. Despite huge global economic burden and the impact on the …
common cause for dementia. Despite huge global economic burden and the impact on the …
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease
BS Thawkar, G Kaur - Journal of neuroimmunology, 2019 - Elsevier
Microglial activation is a distinguished attribute in many neurodegenerative diseases of
aging. Compelling evidence suggests that neuroinflammation stimulated by microglia, the …
aging. Compelling evidence suggests that neuroinflammation stimulated by microglia, the …
[HTML][HTML] Stigmasterol attenuates inflammatory response of microglia via NF-κB and NLRP3 signaling by AMPK activation
Alzheimer's disease (AD) is the most common cause of dementia in the elderly. Although its
pathogenesis remains unclear, studies have indicated microglia-mediated …
pathogenesis remains unclear, studies have indicated microglia-mediated …
Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis
CC Tan, JT Yu, HF Wang, MS Tan… - Journal of …, 2014 - content.iospress.com
Background: The role of currently available drugs for Alzheimer's disease (AD) has been
controversial, with some national formularies restricting their use, and health economists …
controversial, with some national formularies restricting their use, and health economists …
Physical activity can improve cognition in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials
Z Du, Y Li, J Li, C Zhou, F Li, X Yang - Clinical interventions in …, 2018 - Taylor & Francis
Background/objective Alzheimer's disease (AD) is mainly characterized by decline of
cognitive functions such as memory and learning, which has a high prevalence and poor …
cognitive functions such as memory and learning, which has a high prevalence and poor …
The role of endoplasmic reticulum stress in neurodegenerative disease
C Xiang, Y Wang, H Zhang, F Han - Apoptosis, 2017 - Springer
The endoplasmic reticulum (ER) is an important organelle involved in cellular homeostasis
and control of protein quality. Unfolded protein response (UPR) is a cellular response to ER …
and control of protein quality. Unfolded protein response (UPR) is a cellular response to ER …
Necroptosis in neurodegenerative diseases: a potential therapeutic target
S Zhang, M Tang, H Luo, C Shi, Y Xu - Cell death & disease, 2017 - nature.com
Neurodegenerative diseases are a group of chronic progressive disorders characterized by
neuronal loss. Necroptosis, a recently discovered form of programmed cell death, is a cell …
neuronal loss. Necroptosis, a recently discovered form of programmed cell death, is a cell …
[HTML][HTML] Rate of early onset Alzheimer's disease: a systematic review and meta-analysis
XC Zhu, L Tan, HF Wang, T Jiang, L Cao… - Annals of …, 2015 - ncbi.nlm.nih.gov
It is generally accepted that the population rate of early onset Alzheimer's disease (EOAD) in
Alzheimer's disease (AD) is 1-2%. However, the true population based rate of EOAD has …
Alzheimer's disease (AD) is 1-2%. However, the true population based rate of EOAD has …